Pharmacists in Dekalb, Illinois


29 Pharmacists found in Dekalb
female pharmacist

Dr. Kristi Stice, PHARM.D.


Pharmacist
1 Kish Hospital Dr, Dekalb, IL 60115
815-756-1521    

male pharmacist

Mr. Lynn F Laseman, BS PHARMACY


Pharmacist
810 S 4th St, Dekalb, IL 60115
815-758-8995    

female pharmacist

Maitri Desai, RPH


Pharmacist
1022 W Lincoln Hwy, Dekalb, IL 60115
815-748-0648     815-748-0649



male pharmacist

Dr. Matthew Thomas Borris, PHARMD


Pharmacist
100 W Lincoln Hwy, Dekalb, IL 60115
815-756-1815    

male pharmacist

Michael John Borak



975 S Annie Glidden Road, Schnucks Market Inc, Dekalb, IL 60115
815-748-6202     815-748-6202

male pharmacist

Mitchell Webster, PHARMD


Pharmacist
2555 Sycamore Rd, Dekalb, IL 60115
815-787-6971    

female pharmacist

Dr. Nimah Patoli, PHARMD


Pharmacist
1022 W Lincoln Hwy, Dekalb, IL 60115
815-748-0648    

male pharmacist

Raymond Horan Jr.


Pharmacist
1322 Sycamore Rd, Dekalb, IL 60115
815-756-1328     815-756-5607

male pharmacist

Robert Anthony Tamblyn, R.PH.


Pharmacist
810 S 4th St, Dekalb, IL 60115
815-761-3237     815-748-3784

female pharmacist

Sudha Rani Veerapaneni


Pharmacist
2300 Sycamore Rd, Dekalb, IL 60115
815-758-6284     815-758-6204

female pharmacist

Dr. Theresa M Heitz, PHARM D.


Pharmacist
2555 Sycamore Rd, Dekalb, IL 60115
815-787-6971     815-787-6971

male pharmacist

Timothy James Lehan, RPH


Pharmacist
1407 S 4th St, Dekalb, IL 60115
815-758-0911     815-758-2669

male pharmacist

Todd Lynn Green, RPH


Pharmacist
100 W Lincoln Hwy, Dekalb, IL 60115
815-756-1815    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.